ConductScience.org, home

Paper19852963

Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma.

Lok AS and 11 others. Gastroenterology, 2010. Cited by 475 papers, by iCite.

Cite this record

ConductScience Library. Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma. Papers, record 19852963. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19852963

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma.
PubMed
Journal
Gastroenterology
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
475
iCite
Relative citation ratio, by iCite
12.9
iCite
Revised in PubMed
2025-05-29
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lok ASAnna S
2Sterling RKRichard K
3Everhart JEJames E
4Wright ECElizabeth C
5Hoefs JCJohn C
6Di Bisceglie AMAdrian M
7Morgan TRTimothy R
8Kim HYHae-Young
9Lee WMWilliam M
10Bonkovsky HLHerbert L
11Dienstag JLJules L
12HALT-C Trial GroupGroup

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BiomarkersMajor topic
Biomarkers, TumorMajor topic
Carcinoma, HepatocellularMajor topic
Liver NeoplasmsMajor topic
Protein PrecursorsMajor topic
alpha-FetoproteinsMajor topic
Adult
Case-Control Studies
Female
Humans
Liver
Male
Middle Aged
Prothrombin
Randomized Controlled Trials as Topic
Sensitivity and Specificity
Ultrasonography

Source PubMed

Download CSV of topics

Grants46

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
N01-DK-9-2325NIDDK NIH HHSUnited StatesN01DK092325PubMed and NIHNIH RePORTER
1 UL1 RR024986NCRR NIH HHSUnited StatesUL1RR024986PubMed and NIHNIH RePORTER
1 UL1 RR025758-01NCRR NIH HHSUnited StatesUL1RR025758PubMed and NIHNIH RePORTER
1 UL1 RR024982-01NCRR NIH HHSUnited StatesUL1RR024982PubMed and NIHNIH RePORTER
N01-DK-9-2320NIDDK NIH HHSUnited StatesN01DK092320PubMed and NIHNIH RePORTER
M01 RR001066NCRR NIH HHSUnited StatesM01RR001066PubMed and NIHNIH RePORTER
M01 RR000065NCRR NIH HHSUnited StatesM01RR000065PubMed and NIHNIH RePORTER
UL1 RR024982NCRR NIH HHSUnited StatesUL1RR024982PubMed and NIHNIH RePORTER
N01-DK-9-2322NIDDK NIH HHSUnited StatesN01DK092322PubMed and NIHNIH RePORTER
M01 RR000043NCRR NIH HHSUnited StatesM01RR000043PubMed and NIHNIH RePORTER
UL1 RR024986NCRR NIH HHSUnited StatesUL1RR024986PubMed and NIHNIH RePORTER
M01RR-00042NCRR NIH HHSUnited StatesM01RR000042PubMed and NIHNIH RePORTER
1 UL1 RR 025780-01NCRR NIH HHSUnited StatesUL1RR025780PubMed and NIHNIH RePORTER
N01 DK092324NIDDK NIH HHSUnited StatesN01DK092324PubMed and NIHNIH RePORTER
N01 DK092321NIDDK NIH HHSUnited StatesN01DK092321PubMed and NIHNIH RePORTER
M01RR-00065NCRR NIH HHSUnited StatesM01RR000065PubMed and NIHNIH RePORTER
N01-DK-9-2328NIDDK NIH HHSUnited StatesN01DK092328PubMed and NIHNIH RePORTER
N01 DK092320NIDDK NIH HHSUnited StatesN01DK092320PubMed and NIHNIH RePORTER
N01-DK-9-2318NIDDK NIH HHSUnited StatesN01DK092318PubMed and NIHNIH RePORTER
N01-DK-9-2324NIDDK NIH HHSUnited StatesN01DK092324PubMed and NIHNIH RePORTER

See all 46 grantsDownload CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00006164Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard TreatmentDerived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118848939Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease.Gastroenterology2009https://conductscience.org/library/papers/18848939PubMed
216911460Clinical features of hepatitis C virus-related hepatocellular carcinoma and their association with alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II.Liver Int2006https://conductscience.org/library/papers/16911460PubMed
311156649Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.Gut2001https://conductscience.org/library/papers/11156649PubMed
415465617Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders.Control Clin Trials2004https://conductscience.org/library/papers/15465617PubMed
53036940Production of abnormal prothrombin (des-gamma-carboxy prothrombin) by hepatocellular carcinoma. A clinical and experimental study.J Hepatol1987https://conductscience.org/library/papers/3036940PubMed
616136646Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial.J Hepatol2005https://conductscience.org/library/papers/16136646PubMed
710520857Screening for hepatocellular carcinoma in patients with advanced cirrhosis.Am J Gastroenterol1999https://conductscience.org/library/papers/10520857PubMed
811941963Early diagnosis of hepatocellular carcinoma using a sensitive assay for serum des-gamma-carboxy prothrombin: a prospective study.Hepatogastroenterology2002https://conductscience.org/library/papers/11941963PubMed
916848811Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size.Am J Gastroenterol2006https://conductscience.org/library/papers/16848811PubMed
107515408Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis.J Hepatol1994https://conductscience.org/library/papers/7515408PubMed
114528109Vitamin K dependent modifications of glutamic acid residues in prothrombin.Proc Natl Acad Sci U S A1974https://conductscience.org/library/papers/4528109PubMed
1212834318Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis.Ann Intern Med2003https://conductscience.org/library/papers/12834318PubMed
1315042359Randomized controlled trial of screening for hepatocellular carcinoma.J Cancer Res Clin Oncol2004https://conductscience.org/library/papers/15042359PubMed
1419052125Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon.N Engl J Med2008https://conductscience.org/library/papers/19052125PubMed
1512717392Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients.Hepatology2003https://conductscience.org/library/papers/12717392PubMed
1610763956Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.Am J Gastroenterol2000https://conductscience.org/library/papers/10763956PubMed
1711350553Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America.J Gastroenterol Hepatol2001https://conductscience.org/library/papers/11350553PubMed
186201741Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma.N Engl J Med1984https://conductscience.org/library/papers/6201741PubMed
1910738213Unique clinical characteristics of patients with hepatocellular carcinoma who present with high plasma des-gamma-carboxy prothrombin and low serum alpha-fetoprotein.Cancer2000https://conductscience.org/library/papers/10738213PubMed
207506227Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma.Hepatology1994https://conductscience.org/library/papers/7506227PubMed

See all 38 referencesDownload CSV of references

Cited by285

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 475 citations.

PMIDTitleJournalYearIn PapersSource
42976211PIVKA-II and hematological parameters in hepatocellular carcinoma and non-malignant chronic liver disease: A case-control biomarker comparison in a hepatitis-endemic population.PLoS One2026https://conductscience.org/library/papers/42976211PubMed
42936682Isolated Metachronous Splenic Metastasis Following Discontinuation of PD-1 Inhibitor Therapy in Hepatocellular Carcinoma: A Rare Pattern of Late Recurrence - A Case Report.J Hepatocell Carcinoma2026https://conductscience.org/library/papers/42936682PubMed
42543507Lock-Open: An AND Logic-Gated, Entropy-Driven DNA Nanowalker for Highly Sensitive Detection of UDG and APE1 Activities in Hepatocellular Carcinoma.Adv Healthc Mater2026https://conductscience.org/library/papers/42543507PubMed
42403532The Application of Nanomaterials in the Detection of Liver Cancer Biomarkers.Int J Nanomedicine2026https://conductscience.org/library/papers/42403532PubMed
41981115The versatile interplay between steatotic liver disease and liver cancer.Nat Rev Cancer2026https://conductscience.org/library/papers/41981115PubMed
41976309Blu-Ray-Based Quantification of CD98+ Extracellular Vesicles for Early Detection of Hepatocellular Carcinoma.Cancers (Basel)2026https://conductscience.org/library/papers/41976309PubMed
41907234Case Report: Serum AKR1B10 as a complementary marker for the detection of AFP-negative hepatocellular carcinoma - a report of two cases.Front Med (Lausanne)2026https://conductscience.org/library/papers/41907234PubMed
41815132Pathological features and biomarkers of hepatocellular carcinoma: a bibliometric analysis from 2005 to 2025.Transl Cancer Res2026https://conductscience.org/library/papers/41815132PubMed
41770443Diagnostic utility of postmortem serum tumor markers for identifying primary malignancies: A forensic evaluation of six markers.Forensic Sci Med Pathol2026https://conductscience.org/library/papers/41770443PubMed
41659855Integration of single-cell sequencing, transcriptome sequencing, and machine learning for constructing and validating histone acetylation-related prognostic risk models in hepatocellular carcinoma.Front Immunol2026https://conductscience.org/library/papers/41659855PubMed
41647967Novel blood signature for hepatocellular carcinoma screening.ESMO Gastrointest Oncol2025https://conductscience.org/library/papers/41647967PubMed
41294084Fontan-Associated Liver Disease: Trends Over Time and Relationship With Outcomes.J Am Heart Assoc2025https://conductscience.org/library/papers/41294084PubMed
40689369Comparison of the GALAD, GAAP, and ASAP Scores for Hepatocellular Carcinoma Detection in Patients With Chronic Liver Diseases.J Clin Exp Hepatol2025https://conductscience.org/library/papers/40689369PubMed
40566050Combined Model for the Diagnosis of Hepatocellular Carcinoma: A Pilot Study Comparing the Liver to Spleen Volume Ratio and Liver Vein to Cava Attenuation.J Clin Med2025https://conductscience.org/library/papers/40566050PubMed
40504251Cancer surveillance in biliary atresia patients with native liver survival: Standardizing monitoring and follow-up.Pediatr Surg Int2025https://conductscience.org/library/papers/40504251PubMed
40074769Integrated analysis and experimental validation reveal the prognostic and immunological features associated with coagulation in hepatocellular carcinoma.Sci Rep2025https://conductscience.org/library/papers/40074769PubMed
39807403Correlation Between Dynamic Contrast-Enhanced CT Imaging Signs and Differentiation Grade and Microvascular Invasion of Hepatocellular Carcinoma.J Hepatocell Carcinoma2025https://conductscience.org/library/papers/39807403PubMed
39685591Role of Proteins in Oncology: Advances in Cancer Diagnosis, Prognosis, and Targeted Therapy-A Narrative Review.J Clin Med2024https://conductscience.org/library/papers/39685591PubMed
39682122Hepatocellular Carcinoma Surveillance Strategies: Major Guidelines and Screening Advances.Cancers (Basel)2024https://conductscience.org/library/papers/39682122PubMed
39649218Unlocking the diagnostic potential of vascular endothelial growth factor and interleukin-17: Advancing early detection strategies for hepatocellular carcinoma.World J Gastrointest Surg2024https://conductscience.org/library/papers/39649218PubMed

See all 285 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACE1636PubTator's text mininghttps://conductscience.org/library/genes/1636NCBI Gene
AFP174PubTator's text mininghttps://conductscience.org/library/genes/174NCBI Gene
F22147PubTator's text mininghttps://conductscience.org/library/genes/2147NCBI Gene
IFNA13439PubTator's text mininghttps://conductscience.org/library/genes/3439NCBI Gene

Download CSV of genes

Drugs2

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targetsSource
PEGINTERFERON ALFA-2ACHEMBL1201560Derived from the trial1https://conductscience.org/library/drugs/CHEMBL1201560ChEMBL
RIBAVIRINCHEMBL1643Derived from the trial1https://conductscience.org/library/drugs/CHEMBL1643ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19852963

GET https://conductscience.org/api/papers/v1/19852963/grants?page=2